argenx SE (EBR:ARGX)
552.00
+0.20 (0.04%)
Mar 28, 2025, 5:35 PM CET
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
€1,358,062
Profits / Employee
€503,210
Market Cap
33.67B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UCB SA | 9,378 |
Fagron NV | 3,828 |
Ion Beam Applications | 2,145 |
Nyxoah | 147 |
Onward Medical | 99 |
Hyloris Pharmaceuticals | 41 |
Sequana Medical NV | 62 |
Celyad Oncology | 19 |
argenx SE News
- 3 days ago - Looking Into argenx's Recent Short Interest - Benzinga
- 5 days ago - Argenx: The Magic May Be Already Priced In - Seeking Alpha
- 9 days ago - P/E Ratio Insights for argenx - Benzinga
- 23 days ago - argenx SE (ARGX) Announces Promising Data for VYVGART at AAN Annual Meeting - GuruFocus
- 23 days ago - argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 4 weeks ago - argenx targets 12,000 CIDP patients with VYVGART expansion in 2025 - Seeking Alpha
- 4 weeks ago - argenx SE (ARGX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - argenx: Vyvgart's Sales Momentum Improves, Clinical Data Updates From A Key Competitor Imminent - Seeking Alpha